EGFR targeted inhibitors in esophageal cancer / 国际肿瘤学杂志
Journal of International Oncology
; (12): 922-925, 2010.
Article
em Zh
| WPRIM
| ID: wpr-385774
Biblioteca responsável:
WPRO
ABSTRACT
Overexpression of epidermal growth factor receptor (EGFR) in esophageal cancer has been related to tumor grade, vascular invasion and metastasis. The level of EGFR expression may be a predictive marker of esophageal caneer's sensitivity to chemoradiotherapy. EGFR inhibitors have been indicated as an effective targeted therapy, and promising results have been observed in phase Ⅱ and Ⅲ clinical trials.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Prognostic_studies
Idioma:
Zh
Revista:
Journal of International Oncology
Ano de publicação:
2010
Tipo de documento:
Article